These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 11237563)
1. Re: Duffy phenotype does not influence the clinical severity of sickle cell disease. Wood EM; Woolley I Clin Immunol; 2001 Mar; 98(3):383-4. PubMed ID: 11237563 [No Abstract] [Full Text] [Related]
2. Chapter 9 the duffy antigen receptor for chemokines. Rot A; Horuk R Methods Enzymol; 2009; 461():191-206. PubMed ID: 19480920 [TBL] [Abstract][Full Text] [Related]
3. Duffy phenotype does not influence the clinical severity of sickle cell disease. Schnog JB; Keli SO; Pieters RA; Rojer RA; Duits AJ Clin Immunol; 2000 Sep; 96(3):264-8. PubMed ID: 10964545 [TBL] [Abstract][Full Text] [Related]
4. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Tournamille C; Le Van Kim C; Gane P; Le Pennec PY; Roubinet F; Babinet J; Cartron JP; Colin Y Blood; 1998 Sep; 92(6):2147-56. PubMed ID: 9731074 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the Duffy erythrocyte chemokine receptor in Italian patients with Behçet's disease. Pittoni V; Vaglio S; Magrini L; Accorinti M; Pivetti-Pezzi P; Girelli G; Valesini G Rheumatol Int; 2003 May; 23(3):116-20. PubMed ID: 12739041 [TBL] [Abstract][Full Text] [Related]
6. Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients. Nebor D; Durpes MC; Mougenel D; Mukisi-Mukaza M; Elion J; Hardy-Dessources MD; Romana M Clin Immunol; 2010 Jul; 136(1):116-22. PubMed ID: 20347396 [TBL] [Abstract][Full Text] [Related]
8. Association between Duffy antigen receptor expression and disease severity in sickle cell disease patients. Farawela HM; El-Ghamrawy M; Farhan MS; Soliman R; Yousry SM; AbdelRahman HA Hematology; 2016 Sep; 21(8):474-9. PubMed ID: 26917322 [TBL] [Abstract][Full Text] [Related]
9. Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8. Etienne-Julan M; Belloy MS; Decastel M; Dougaparsad S; Ravion S; Hardy-Dessources MD Haematologica; 2004 Jul; 89(7):863-4. PubMed ID: 15257940 [TBL] [Abstract][Full Text] [Related]
10. A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression. Tamasauskas D; Powell V; Saksela K; Yazdanbakhsh K Blood; 2001 Jun; 97(11):3651-4. PubMed ID: 11369664 [TBL] [Abstract][Full Text] [Related]
11. Lack of association between the Duffy antigen receptor for chemokines (DARC) expression and clinical outcome of children with sickle cell anemia. Araujo NB; Domingos IF; Medeiros FS; Hatzlhofer BL; Mendonça TF; Vasconcelos LR; Cavalcanti Mdo S; Araujo AS; Oliveira Mdo C; Lucena-Araujo AR; Bezerra MA Immunol Lett; 2015 Aug; 166(2):140-2. PubMed ID: 26045319 [No Abstract] [Full Text] [Related]
12. The value of DNA analysis for antigens in the Duffy blood group system. Castilho L Transfusion; 2007 Jul; 47(1 Suppl):28S-31S. PubMed ID: 17593283 [No Abstract] [Full Text] [Related]
13. HIV nephropathy and the Duffy antigen/receptor for Chemokines in African Americans. Woolley IJ; Kalayjian R; Valdez H; Hamza N; Jacobs G; Lederman MM; Zimmerman PA J Nephrol; 2001; 14(5):384-7. PubMed ID: 11730271 [TBL] [Abstract][Full Text] [Related]
14. Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion. Singh SK; Singh AP; Pandey S; Yazdani SS; Chitnis CE; Sharma A Biochem J; 2003 Aug; 374(Pt 1):193-8. PubMed ID: 12775212 [TBL] [Abstract][Full Text] [Related]
15. The effect of Duffy antigen receptor for chemokines on severity in sickle cell disease. Drasar ER; Menzel S; Fulford T; Thein SL Haematologica; 2013 Aug; 98(8):e87-9. PubMed ID: 23753024 [No Abstract] [Full Text] [Related]
16. Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens. Wang R; Arevalo-Herrera M; Gardner MJ; Bonelo A; Carlton JM; Gomez A; Vera O; Soto L; Vergara J; Bidwell SL; Domingo A; Fraser CM; Herrera S Eur J Immunol; 2005 Jun; 35(6):1859-68. PubMed ID: 15864779 [TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion. Singh AP; Ozwara H; Kocken CH; Puri SK; Thomas AW; Chitnis CE Mol Microbiol; 2005 Mar; 55(6):1925-34. PubMed ID: 15752210 [TBL] [Abstract][Full Text] [Related]
18. Development of Duffy transgenic mouse: in vivo expression of human Duffy gene with -33T-->C promoter mutation in non-erythroid tissues. Chaudhuri A; Yuen G; Fang F; Storry J Br J Haematol; 2004 Nov; 127(3):356-9. PubMed ID: 15491299 [TBL] [Abstract][Full Text] [Related]
19. The prospects of light from DARC. Snounou G Trends Parasitol; 2002 Sep; 18(9):383-4. PubMed ID: 12377249 [No Abstract] [Full Text] [Related]
20. Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimization. Yazdani SS; Shakri AR; Pattnaik P; Rizvi MM; Chitnis CE Biotechnol Lett; 2006 Jul; 28(14):1109-14. PubMed ID: 16794771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]